Completed
Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease.
NCT00798005
- Conditions
- Peripheral Arterial Occlusive Disease 1, Severe Peripheral Artery Occlusive Disease
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States